Investment analysts and portfolio managers look into their crystal balls to predict the best-performing stocks for the year ahead.
Company expects US FDA decision on Maxigesic tablets and IV over next six months.
Inflation and reopenings in the spotlight as post-GFC bull run slows.
But manager estimates full-year fees from CDC will be around half last year's level.
Commerce Commission has concerns about Ampol's proposed Gull divestment.
Equity investment deepens relationship with Gaming Innovation Group.
Official Information Act release also contradicts statement provided by SkyCity to NBR.
But board backs appointment ahead of challenging turnaround.
The former Bendon owner has bought Cenntro Auto Group.
Aussie store stock shifted to online channels during lockdown, says James Glasson.
